Wolfe Research Initiates WST at Outperform With $375 Target
Brokerage sets price target implying 40x 2027 EPS, citing WST’s historical premium to S&P 500 and sector peers. Wolfe Research initiated coverage of West Pharmaceutical Services Inc (WST) with an Outperform rating and a $375 price target. The target reflects 40 times proje